Labeling remains one of the most intense negotiations that industry has with the FDA — whether it’s the battle of getting a label approved or conflicts over postmarket revisions.
Join an elite group of drug and biologic industry executives, FDA officials, industry attorneys and thought leaders to discuss and debate the future and implications of the ongoing tug-of-war that is pharmaceutical labeling and revision.
2012 Highlighted Speakers Include:
For 2012 exhibit options and sponsorship packages contact Colette McMullen, Director, Business Development at (703) 538-7642 or email@example.com
The National Press Club
529 14th Street, NW
Washington, DC 20045
Tel: +1 (202) 662-7500
Register for 2012:
Early Bird Fee
Before Oct. 5, 2012
Oct. 6 – Oct. 17, 2012
Send Your Team for Maximum Benefit
Call (888) 838-5578 in the U.S. or +1 (703) 538-7600
Payment is required by the date of the conference. We accept American Express, Visa and MasterCard. Make checks payable to FDAnews.
Or, register by phone: toll free (888) 838-5578 (inside the U.S.) or +1 (703) 538-7600.
Cancellations and Substitutions
Written cancellations received at least 21 calendar days prior to the start date of the event will receive a refund less a $200 administration fee. No cancellations will be accepted nor refunds issued within 21 calendar days from the start date of the event. A credit for the amount paid may be transferred to any future FDAnews event. Substitutions may be made at any time. No-shows will be charged the full amount. In the event that FDAnews cancels the event, FDAnews is not responsible for any airfare, hotel, other costs or losses incurred by registrants. Some topics and speakers may be subject to change without notice.
Copyright ©2019. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing